Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immix Biopharma, Inc. | 181,004 | reported | 22 May 2026 | tx 9+295,731 |
| Genasys Inc. | 25,000 | reported | 10 May 2012 | tx 2+75,000 |
| Prometheus Biosciences, Inc. | 0 | reported | 16 Jun 2023 | tx 8+25,283−55,283 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 6,250 | 0.00 USD | |
| 22 May 2026 | GRANT_AWARD | Immix Biopharma, Inc. | 12,500 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | Immix Biopharma, Inc. | 33,000 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 33,000 | 0.00 USD | deriv |
| 20 May 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 74,241 | — | |
| 15 May 2024 | GRANT_AWARD | Immix Biopharma, Inc. | 87,740 | 0.00 USD | |
| 12 Sept 2023 | PURCHASE | Immix Biopharma, Inc. | 13,000 | 2.96 USD | first after silence |
| 11 Aug 2023 | GRANT_AWARD | Immix Biopharma, Inc. | 20,000 | 0.00 USD | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 2,674 | — | |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 21,526 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 1,083 | — | deriv |
| 16 Jun 2023 | OTHER | Prometheus Biosciences, Inc. | 30,000 | — | deriv |
| 19 May 2023 | GRANT_AWARD | Prometheus Biosciences, Inc. | 2,174 | 0.00 USD | |
| 14 Jul 2022 | GRANT_AWARD | Immix Biopharma, Inc. | 16,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Prometheus Biosciences, Inc. | 21,526 | 0.00 USD | deriv |
| 14 Nov 2021 | GRANT_AWARD | Prometheus Biosciences, Inc. | 1,083 | 0.00 USD | deriv |
| 16 Mar 2021 | PURCHASE | Prometheus Biosciences, Inc. | 500 | 19.00 USD | |
| 10 May 2012 | GRANT_AWARD | Genasys Inc. | 25,000 | 0.00 USD | deriv |
| 04 May 2010 | GRANT_AWARD | Genasys Inc. | 50,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 12 Sept 2023.